Posts Tagged ‘prescription’
Health Care Fraud, Prescription Theft Lead To Significant Losses
ABC News: “A four month ‘Nightline’ investigation into Medicare fraud makes one thing perfectly clear: this is a crime that pays and pays and pays. The federal government admits that a staggering $60 billion is stolen from tax payers through Medicare scams every year. Some experts believe the number is more than twice that…
New Research Gives Insight To The Frequency Of ‘Doctor Shopping’ Occurring Within Prescription Monitoring Programs
Research presented at the American Academy of Pain Medicine’s 26th Annual Meeting provides early published data analyzing information gathered from California’s prescription monitoring program, known as the Controlled Substances Utilization Review and Evaluation System (CURES)…
State Watch: Walgreen Medicaid Prescription Threat, Conn. Insurance Claims
A roundup of state health news: The (Spokane, Wash.) Spokesman-Review: “Walgreen Co. said it will stop filling Medicaid prescriptions at about half of its pharmacies in Washington next month because of continued reimbursement reductions” (Stucke, 1/14). The Wall Street Journal: It’s not the first time Walgreen has made this type of threat…
Fear Of Prescription Drug Abuse Affects Pain Management
Millions of Americans with significant or chronic pain associated with their medical problems are being under-treated as physicians increasingly fail to provide comprehensive pain treatment – either due to inadequate training, personal biases or fear of prescription drug abuse…
Pain management failing as fears of prescription drug abuse rise
Millions of Americans with significant or chronic pain associated with their medical problems are being under-treated as physicians increasingly fail to provide comprehensive pain treatment — either due to inadequate training, personal biases or fear of prescription drug abuse.
CMS Proposes New Rules For Medicare Advantage And Prescription Drug Plans To Better Serve Beneficiaries
The Centers for Medicare & Medicaid Services (CMS) today issued a proposed rule to improve performance of prescription drug and health plans by strengthening standards to participate in the Medicare program. Over the next 60 days, CMS will receive comments on the proposed revisions to the Medicare Advantage (MA) program (Part C) and Prescription Drug benefit program (Part D).
Nutra Pharma Announces Nyloxin Rx, A Prescription Analgesic For The Treatment Of Severe (Stage 3) Chronic Pain
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today its intent to launch a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain. Nyloxin Rx is a prescription pain reliever produced by Nutra Pharma’s wholly-owned drug discovery subsidiary, ReceptoPharm.
Statement By Medicare Rights Center On CMS’s Announcement Of Premium Rates And Low-Income Subsidy Benchmarks For Medicare Prescription Drug Plans
The Centers for Medicare & Medicaid Services has taken important steps to minimize disruptions in drug coverage and to ensure a choice of drug plans for low-income people with Medicare. As a result of CMS’s actions, low-income people with Medicare in all parts of the country will have a choice of at least four drug plans, and one million low-income people with Medicare will be able to keep their current zero-premium drug plan next year.
Most Appropriate Treatment Strategy: Extension Of Vaccination Policy Or Prescription Of Anti-Influenza For Healthy Adults?
The use of antiviral drugs for the treatment of people presenting with symptoms is unlikely to be the most suitable approach during a seasonal outbreak. This is the conclusion of a study published Online First and in an upcoming edition of The Lancet Infectious Diseases. The review is the work of Dr Jane Burch and Professor Lesley Stewart, Centre for Reviews and Dissemination, University of York, UK, and collaborators.
Mayo Clinic Proceedings: A Comprehensive Review Of Addiction To Prescription Painkillers Among Patients And Physicians
Chemical dependency and recovery in patients and physicians are closely examined in a series of articles and editorials in the July 2009 issue of Mayo Clinic Proceedings. The subject is especially timely. As the immense challenges, including potential tragedies, of prescription chemical addiction and abuse are being discussed, these articles offer crucial overview, direction and optimism.
Rx Drug Compare
Translator
By N2H